Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6911)
All Articles published online
|
Publishing Process of This Article
|
Apr 15, 2021 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Guan MC, Wang MD, Liu SY, Ouyang W, Liang L, Pawlik TM, Xu QR, Huang DS, Shen F, Zhu H, Yang T. Early diagnosis and therapeutic strategies for hepatocellular carcinoma: From bench to bedside. World J Gastrointest Oncol 2021; 13(4): 197-215 [PMID: 33889272 DOI: 10.4251/wjgo.v13.i4.197] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i4/197.htm |
| Number | Citing Articles |
| 1 |
Chaokun Yan, Mengyuan Li, Zhihao Suo, Jun Zhang, Jianlin Wang, Ge Zhang, Wenjuan Liang, Huimin Luo. Biomarkers Identification of Hepatocellular Carcinoma Based on Multiomics
Data Integration and Graph-embedded Deep Neural Network. Current Bioinformatics 2023; 18(6): 459 doi: 10.2174/1574893618666230227122331
|
| 2 |
Andreia P Alves, Sandra M Rocha, Ana C Mamede, Patrícia C Braga, Marco G Alves, Pedro F Oliveira, Filomena M Botelho, Cláudio J Maia. Differential response of hepatocellular carcinoma glycolytic metabolism and oxidative stress markers after exposure to human amniotic membrane proteins. Molecular Biology Reports 2022; 49(8): 7731 doi: 10.1007/s11033-022-07598-5
|
| 3 |
Wei Ouyang, Ming-Da Wang, Ming-Cheng Guan, Yong-Kang Diao, Li-Yang Sun, Nan-Ya Wang, Feng Shen, Hong Zhu, Tian Yang. Diagnostic performance comparisons of two commonly used multi-biomarker-based scores for detection of hepatocellular carcinoma in non-alcoholic fatty liver disease. iLIVER 2024; 3(2): 100098 doi: 10.1016/j.iliver.2024.100098
|
| 4 |
Mengxiang Liu, Yanrong Wen. Point-of-care testing for early-stage liver cancer diagnosis and personalized medicine: Biomarkers, current technologies and perspectives. Heliyon 2024; 10(19): e38444 doi: 10.1016/j.heliyon.2024.e38444
|
| 5 |
Min Yao, Jian-Jun Wang, Xi-Yu Chen, Wen-Li Sai, Jie Yang, De-Feng Wang, Li Wang, Deng-Fu Yao. Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesis. Hepatobiliary & Pancreatic Diseases International 2023; 22(3): 263 doi: 10.1016/j.hbpd.2022.11.004
|
| 6 |
Innocent Benjamin, Terkumbur E. Gber, Hitler Louis, Tabe N. Ntui, Emmanuella I. Oyo-Ita, Tomsmith O. Unimuke, Moses M. Edim, Adedapo S. Adeyinka. Modelling of Aminothiophene-Carbonitrile Derivatives as Potential Drug Candidates for Hepatitis B and C. Iranian Journal of Science and Technology, Transactions A: Science 2022; 46(5): 1399 doi: 10.1007/s40995-022-01355-w
|
| 7 |
Jianwei Wang, Xiaowen Guan, Ning Shang, Di Wu, Zihan Liu, Zhenzhen Guan, Zhizi Zhang, Zhongzhen Jin, Xiaoyi Wei, Xiaoran Liu, Mingzhu Song, Weijun Zhu, Guifu Dai. Dysfunction of CCT3-associated network signals for the critical state during progression of hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(4): 167054 doi: 10.1016/j.bbadis.2024.167054
|
| 8 |
Ming-Cheng Guan, Wei Ouyang, Si-Yu Liu, Li-Yang Sun, Wei-Yue Chen, Xiang-Min Tong, Hong Zhu, Tian Yang. Alpha-fetoprotein, protein induced by vitamin K absence or antagonist-II, lens culinaris agglutinin-reactive fraction of alpha-fetoprotein alone and in combination for early detection of hepatocellular carcinoma from nonalcoholic fatty liver disease: A multicenter analysis. Hepatobiliary & Pancreatic Diseases International 2022; 21(6): 559 doi: 10.1016/j.hbpd.2022.05.003
|
| 9 |
Kareem A. Attallah, Mohamed S. Albannan, Khaled Farid, Sherine M. Rizk, Nevine Fathy. HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study. Technology in Cancer Research & Treatment 2024; 23 doi: 10.1177/15330338241234790
|
| 10 |
Mingda Wang, Guojun Qian, Hongmei Xiao, Xingkai Liu, Liyang Sun, Zhong Chen, Kongying Lin, Lanqing Yao, Chao Li, Lihui Gu, Jiahao Xu, Xiaodong Sun, Wei Qiu, Timothy M Pawlik, Wan Yee Lau, Guoyue Lv, Feng Shen, Tian Yang. Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patients. The Oncologist 2024; doi: 10.1093/oncolo/oyae139
|
| 11 |
Lingli Huang, Hui Xu, Tianyu Wu, Gaofeng Li, San Jun Shi. Hedyotis diffusa Willd. Suppresses Hepatocellular Carcinoma via Downregulating AKT/mTOR Pathways. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5210152
|
| 12 |
Gehad A. Saleh, Fatmaelzahraa Abdelfattah Denewar, Khadiga M. Ali, Marwa Saleh, Mahmoud Abdelwahab Ali, Ahmed Shehta, Manar Mansour. Inter-observer reliability and predictive values of triphasic computed tomography for microvascular invasion in hepatocellular carcinoma. Egyptian Journal of Radiology and Nuclear Medicine 2024; 55(1) doi: 10.1186/s43055-024-01354-4
|
| 13 |
Ermiyas Alemayehu, Alebachew Fasil, Hussen Ebrahim, Zewudu Mulatie, Getachew Mesfin Bambo, Alemu Gedefie, Mulugeta Teshome, Abebaw Worede, Melaku Ashagrie Belete. Circulating microRNAs as promising diagnostic biomarkers for hepatocellular carcinoma: a systematic review and meta-analysis. Frontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1353547
|
| 14 |
Ming-Cheng Guan, Shi-Yu Zhang, Qian Ding, Na Li, Ting-Ting Fu, Gui-Xia Zhang, Qian-Qian He, Feng Shen, Tian Yang, Hong Zhu. The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 2023; 12(3): 949 doi: 10.3390/jcm12030949
|
| 15 |
Xiaomo Xiong, Jeff Jianfei Guo. Cost Effectiveness of Tremelimumab Plus Durvalumab for Unresectable Hepatocellular Carcinoma in the USA. PharmacoEconomics 2024; doi: 10.1007/s40273-024-01453-0
|
| 16 |
Yuquan Qian, Timo Itzel, Matthias Ebert, Andreas Teufel. Deep View of HCC Gene Expression Signatures and Their Comparison with Other Cancers. Cancers 2022; 14(17): 4322 doi: 10.3390/cancers14174322
|
| 17 |
Mai M. Al-Oqail, Ebtesam S. Al-Sheddi, Nida N. Farshori, Shaza M. Al-Massarani, Ebtesam N. Alsultan, Javed Ahmad, Abdulaziz A. Al-Khedhairy, Maqsood A. Siddiqui. In vitro anticancer potential of dill seed extract against human hepatocellular carcinoma (Huh-7) cells. Journal of King Saud University - Science 2024; 36(9): 103390 doi: 10.1016/j.jksus.2024.103390
|
| 18 |
Ming-Da Wang, Li-Yang Sun, Guo-Jun Qian, Chao Li, Li-Hui Gu, Lan-Qing Yao, Yong-Kang Diao, Timothy M. Pawlik, Wan Yee Lau, Dong-Sheng Huang, Feng Shen, Tian Yang. Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: A retrospective cohort study. International Journal of Surgery 2022; 105: 106843 doi: 10.1016/j.ijsu.2022.106843
|
| 19 |
Mojca Maticic, J. Cernosa, C. Loboda, J. Tamse, R. Rigoni, E. Duffell, I. Indave, R. Zimmermann, L. Darragh, J. Moura, A. Leicht, T. Windelinckx, M. Jauffret-Roustide, K. Schiffer, T. Tammi. How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023. Harm Reduction Journal 2024; 21(1) doi: 10.1186/s12954-024-01115-6
|
| 20 |
Asif Ahmad Bhat, Muhammad Afzal, Ehssan Moglad, Riya Thapa, Haider Ali, Waleed Hassan Almalki, Imran Kazmi, Sami I. Alzarea, Gaurav Gupta, Vetriselvan Subramaniyan. lncRNAs as prognostic markers and therapeutic targets in cuproptosis-mediated cancer. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01491-0
|
| 21 |
Yanli Liu, Wanmei Liang, Yabin Chang, Zehui He, Meijian Wu, Haozhi Zheng, Xinrong Ke, Minjia Lv, Qingqian Liu, Qinyu Liu, Waner Tang, Qiaoling Huang, Yu Lu, Min He, Qijun Yang, Chunpan Mo, Jiefan Wang, Kunwei Peng, Zhiqun Min, Hang Su, Jingqi Chen. CEP192 is a novel prognostic marker and correlates with the immune microenvironment in hepatocellular carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.950884
|
| 22 |
Rajendra Benny K, Vinitha Tony, Sonia Thanikaivelu, Ravish Sanghi Raju, Rijo Isaac NP, Bedanta Barman, KirubaAllen Samuel Ram, Rohan Samuel Thomas, Neenu Oliver John, Arvind Sathyamurthy, Jeba Karunya Ramireddy, Thomas Samuel Ram. Unveiling the enigma of spontaneous regression in hepatocellular carcinoma: A case report from a tertiary care center in South India. International Journal of Hepatobiliary and Pancreatic Diseases 2024; 14(2): 15 doi: 10.5348/100105Z04RK2024CR
|